Mary J. Grendell
General Counsel bei PROTARA THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Mary J. Grendell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mary J. Grendell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO Public Communications Contact | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO Director of Finance/CFO | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Exp@nets, Inc. | Director of Finance/CFO Director of Finance/CFO | ||
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
| French-American Foundation | Director/Board Member | ||
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Eagleton Institute of Politics | College/University | Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZS PHARMA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
| RAFAEL HOLDINGS, INC. | Real Estate Development | President | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Medical Specialties | Director of Finance/CFO | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ELECTROCORE, INC. | Medical Specialties | Director of Finance/CFO | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Director/Board Member | |
| Pace University | College/University | Undergraduate Degree | |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
G&W Laboratories, Inc.
 G&W Laboratories, Inc. Pharmaceuticals: MajorHealth Technology G&W Laboratories, Inc. engages in the manufacturing and marketing pharmaceutical products. It offers generics and Rx products. The company was founded by Carl Greenblatt in 1919 and is headquartered in South Plainfield, NJ. | Pharmaceuticals: Major | Public Communications Contact | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Gordon College | College/University | Undergraduate Degree | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Nova Southeastern University, Inc. | College/University | Doctorate Degree | |
| Benedictine University | College/University | Graduate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | President | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 48 |
| Israel | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 11 |
| Finance | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 50 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 25 |
| Director of Finance/CFO | 17 |
| Undergraduate Degree | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Luke Beshar | 19 |
| Richard Levy | 16 |
| Gregory Sargen | 15 |
| Michael Solomon | 14 |
| Patrick Fabbio | 13 |
| Cynthia Smith | 13 |
| Barry Flannelly | 10 |
| Jacqueline Zummo | 9 |
| Roger Garceau | 8 |
| Jane Huang | 8 |
| Justine O'Malley | 7 |
| Jesse Shefferman | 7 |
| Hannah Fry | 2 |
- Börse
- Insiders
- Mary J. Grendell
- Unternehmensverbindungen
